Novartis CAR-T therapy Kymriah has been approved by the European Commission for use in patients up to 25 years of age with ALL. Newcastle is one of the first three NHS hospitals to apply to use the CAR-T (chimeric antigen receptor T-cell) therapy.
CAR-T Therapy Kymriah Approved For Use
- 28th February 2020
- 25th February 2020
- 24th February 2020